Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedJan 25, 2022
DataAggregated Company Financials
Companies27
  • 7D-6.4%
  • 3M-21.0%
  • 1Y-46.8%
  • YTD-12.2%

Over the last 7 days, the Biotech industry has dropped 7.3%, driven by declines in PeptiDream and Takara Bio of 6.1% and 5.5%, respectively. Meanwhile, CanBas actually outperformed within the industry, gaining 21% in the last week. However, the industry is down 47% over the past year.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Tue, 25 Jan 2022JP¥1.1tJP¥163.5b-JP¥5,447,358,000.0016.3x
Thu, 23 Dec 2021JP¥1.3tJP¥163.5b-JP¥5,447,524,000.0018.3x
Sat, 20 Nov 2021JP¥1.3tJP¥159.5b-JP¥8,764,958,000.0020.7x
Mon, 18 Oct 2021JP¥1.4tJP¥147.6b-JP¥12,269,440,000.0023.8x
Wed, 15 Sep 2021JP¥1.7tJP¥147.9b-JP¥14,140,440,000.0025.8x
Fri, 13 Aug 2021JP¥1.7tJP¥148.3b-JP¥14,096,440,000.0023.9x
Tue, 08 Jun 2021JP¥1.8tJP¥130.4b-JP¥17,249,632,000.0037.7x
Mon, 01 Mar 2021JP¥1.8tJP¥112.5b-JP¥20,970,087,000.00109.4x
Thu, 03 Dec 2020JP¥1.9tJP¥90.4b-JP¥27,284,135,000.00231x
Sun, 06 Sep 2020JP¥1.8tJP¥82.0b-JP¥25,982,602,000.00141.7x
Wed, 10 Jun 2020JP¥1.8tJP¥80.7b-JP¥31,890,297,000.0090.6x
Tue, 03 Mar 2020JP¥1.3tJP¥77.2b-JP¥30,683,316,000.0065.2x
Fri, 06 Dec 2019JP¥1.6tJP¥79.8b-JP¥25,898,343,000.00145.5x
Mon, 09 Sep 2019JP¥1.6tJP¥79.1b-JP¥17,932,601,000.0067.1x
Sun, 02 Jun 2019JP¥1.6tJP¥78.1b-JP¥15,751,630,000.0078.4x
Wed, 06 Mar 2019JP¥1.6tJP¥75.3b-JP¥17,055,901,000.0082.2x
PE Ratio

88.1x

Total Market Cap: JP¥1.6tTotal Earnings: -JP¥17,055,901,000.00Total Revenue: JP¥75.3b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 16.4x which is lower than its 3-year average PE of 91.0x. It appears they believe that earnings will not grow as fast as they have historically.

Past Earnings Growth: The earnings for companies in the Biotechs industry have improved over the last three years, and revenues for these companies have grown 30% per year. This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Japanese Biotech industry?

Biotech-6.43%

Industry PE: Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 91.0x. However analysts are expecting annual earnings growth of 10%, which is lower than the prior year's growth of 399% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 10% over the next 5 years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4884 Kringle PharmaJP¥698.001.5%
+JP¥91.8m
-40.3%PS11.1x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4592

JP¥1,057.00

SanBio

7D

-15.6%

1Y

-37.1%

4599

JP¥665.00

StemRIM

7D

-15.7%

1Y

-13.3%

4563

JP¥307.00

AnGes

7D

-12.0%

1Y

-74.4%